GSK1292263

Cat. No.: OB0225WX-2263

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: GSK1292263 is a selective chemical agonist of the G-protein-coupled receptor GPR119.

Synonym: 1032823-75-8; GSK-1292263; 3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole; GSK-1292263A; GSK 1292263; GSK-263A; 5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole; 5-(((1-(3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl)-4-piperidinyl)methyl)oxy)-2-(4-(methylsulfonyl)phenyl)pyridine; 5-[[[1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl]methyl]oxy]-2-[4-(methylsulfonyl)phenyl]pyridine; Pyridine, 5-((1-(3-(1-methylethyl)-1,2,4-oxadiazol-5-yl)-4-piperidinyl)methoxy)-2-(4-(methylsulfonyl)phenyl)-; 2-(4-methanesulfonylphenyl)-5-((1-(3-(propan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methoxy)pyridine; 2-(4-methanesulfonylphenyl)-5-({1-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-yl}methoxy)pyridine; 5-[({1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methyl)oxy]-2-[4-(methylsulfonyl)phenyl]pyridine; MFCD18385004

CAS No.: 1032823-75-8

Compound CID: 24996872

Formula: C₂₃H₂₈N₄O₄S

Formula Weight: 456.56

Specification

Relative Density: 1.23 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: GSK1292263 is employed in metabolic research as a selective GPR119 agonist to investigate the stimulation of incretin hormone release and its potential role in enhancing glucose-dependent insulin secretion.